-
1
-
-
0035936007
-
Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1
-
Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001;345:1522-1528.
-
(2001)
N Engl J Med
, vol.345
, pp. 1522-1528
-
-
Gortmaker, S.L.1
Hughes, M.2
Cervia, J.3
-
3
-
-
0037004510
-
The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era
-
Sabin C. The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era. AIDS. 2002;16(Suppl):S61-S68.
-
(2002)
AIDS
, vol.16
, Issue.SUPPL.
-
-
Sabin, C.1
-
4
-
-
4444220301
-
Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving HAART
-
Viani RM, Araneta MRG, Deville JG, et al. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving HAART. Clin Infect Dis. 2004;39:725-731.
-
(2004)
Clin Infect Dis
, vol.39
, pp. 725-731
-
-
Viani, R.M.1
Araneta, M.R.G.2
Deville, J.G.3
-
5
-
-
9144258622
-
Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents
-
Soh CH, Oleske JM, Brady MT, et al. Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet. 2003;362:2045-2051.
-
(2003)
Lancet
, vol.362
, pp. 2045-2051
-
-
Soh, C.H.1
Oleske, J.M.2
Brady, M.T.3
-
6
-
-
0036701627
-
Pediatric HIV in 2002 - A treatable and preventable infection
-
Lyall H. Pediatric HIV in 2002 - a treatable and preventable infection. J Clin Virol. 2002;25:107-119.
-
(2002)
J Clin Virol
, vol.25
, pp. 107-119
-
-
Lyall, H.1
-
7
-
-
0347995130
-
Treatment of antiretroviral-drug-resistant HIV-1 infection
-
Deeks SG. Treatment of antiretroviral-drug-resistant HIV-1 infection. Lancet. 2003;362:2002-2011.
-
(2003)
Lancet
, vol.362
, pp. 2002-2011
-
-
Deeks, S.G.1
-
8
-
-
0348011587
-
Human immunodeficiency virus protease inhibitors
-
Kline MW. Human immunodeficiency virus protease inhibitors. J Pediatr Infect Dis. 2003;22:1085-1087.
-
(2003)
J Pediatr Infect Dis
, vol.22
, pp. 1085-1087
-
-
Kline, M.W.1
-
9
-
-
4444315072
-
Metabolic complications of HIV therapy in children
-
McComsey GA, Leonard E. Metabolic complications of HIV therapy in children. AIDS. 2004;18:1753-1768.
-
(2004)
AIDS
, vol.18
, pp. 1753-1768
-
-
McComsey, G.A.1
Leonard, E.2
-
10
-
-
0036367321
-
The role of protease inhibitor therapy in children with HIV infection
-
Gavin PJ, Yogev R. The role of protease inhibitor therapy in children with HIV infection. Pediatr Drugs. 2002;4:581-607.
-
(2002)
Pediatr Drugs
, vol.4
, pp. 581-607
-
-
Gavin, P.J.1
Yogev, R.2
-
11
-
-
0043206923
-
Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377
-
Floren LC, Wiznia A, Hayashi S, et al. Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377. Pediatrics. 2003;112(Suppl):e220-e227.
-
(2003)
Pediatrics
, vol.112
, Issue.SUPPL.
-
-
Floren, L.C.1
Wiznia, A.2
Hayashi, S.3
-
12
-
-
0037530630
-
The reliability of reports of medical adherence from children with HIV and their adult caregivers
-
Dolezal C, Mellins C, Brackis-Cott E, et al. The reliability of reports of medical adherence from children with HIV and their adult caregivers. J Pediatr Psychol. 2003;28:355-361.
-
(2003)
J Pediatr Psychol
, vol.28
, pp. 355-361
-
-
Dolezal, C.1
Mellins, C.2
Brackis-Cott, E.3
-
13
-
-
0037004627
-
Supervised interruptions of antiretroviral therapy
-
Deeks S, Hirschel B. Supervised interruptions of antiretroviral therapy. AIDS. 2002;16(Suppl):S157-S169.
-
(2002)
AIDS
, vol.16
, Issue.SUPPL.
-
-
Deeks, S.1
Hirschel, B.2
-
14
-
-
0042431969
-
Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus
-
Lawrence J, Mayers DL, Hullsiek KH, et al. for the Study Team of the Terry Beirn Community Programs for Clinical Research on AIDS. Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus. N Engl J Med. 2003;349:837-846.
-
(2003)
N Engl J Med
, vol.349
, pp. 837-846
-
-
Lawrence, J.1
Mayers, D.L.2
Hullsiek, K.H.3
-
16
-
-
0000771140
-
1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age
-
Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. CDC Morb Mortal Wkly Rep. 1994;44:1-10.
-
(1994)
CDC Morb Mortal Wkly Rep
, vol.44
, pp. 1-10
-
-
-
17
-
-
0036532103
-
Nucleoside-analogue(s) reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pre-treated children infected with HIV-1
-
Pediatrics AIDS Clinical Trials Group 377 Study Team
-
Krogstad P, Lee S, Johnson G, et al. Pediatrics AIDS Clinical Trials Group 377 Study Team. Nucleoside-analogue(s) reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pre-treated children infected with HIV-1. Clin Infect Dis. 2002;34:991-1001.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 991-1001
-
-
Krogstad, P.1
Lee, S.2
Johnson, G.3
-
18
-
-
0037318501
-
Practical applications of viral fitness in clinical practice
-
Bates M, Wrin T, Huang W, et al. Practical applications of viral fitness in clinical practice. Curr Opin Infect Dis. 2003;16:11-18.
-
(2003)
Curr Opin Infect Dis
, vol.16
, pp. 11-18
-
-
Bates, M.1
Wrin, T.2
Huang, W.3
-
19
-
-
0042825484
-
Effect of class-specific therapy interruption on persistence of HIV type 1 antiretroviral resistance
-
Campo RE, Rosa I, Lichtenberger PN, et al. Effect of class-specific therapy interruption on persistence of HIV type 1 antiretroviral resistance. AIDS Res Hum Retroviruses. 2003;19:653-656.
-
(2003)
AIDS Res Hum Retroviruses
, vol.19
, pp. 653-656
-
-
Campo, R.E.1
Rosa, I.2
Lichtenberger, P.N.3
-
20
-
-
2142713131
-
The immune response to AIDS virus infection: Good, bad or both
-
Deeks SG, Walker BD. The immune response to AIDS virus infection: good, bad or both. J Clin Invest. 2004;113:808-810.
-
(2004)
J Clin Invest
, vol.113
, pp. 808-810
-
-
Deeks, S.G.1
Walker, B.D.2
-
21
-
-
2342591920
-
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia
-
Karlsson AC, Younger SR, Martin JN, et al. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. AIDS. 2004;18:981-989.
-
(2004)
AIDS
, vol.18
, pp. 981-989
-
-
Karlsson, A.C.1
Younger, S.R.2
Martin, J.N.3
-
22
-
-
9144231780
-
Strong cell-mediated immune responses are associated with the maintenance of low level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1
-
Deeks SG, Martin JN, Sinclair E, et al. Strong cell-mediated immune responses are associated with the maintenance of low level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. J Infect Dis. 2004;189:312-321.
-
(2004)
J Infect Dis
, vol.189
, pp. 312-321
-
-
Deeks, S.G.1
Martin, J.N.2
Sinclair, E.3
-
23
-
-
27144433671
-
Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients
-
Legrand FA, Abadi J, Jordan KA, et al. Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients. AIDS. 2005;19:1575-1585.
-
(2005)
AIDS
, vol.19
, pp. 1575-1585
-
-
Legrand, F.A.1
Abadi, J.2
Jordan, K.A.3
|